Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025, ...

Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

Hyderabad's commercial real estate market booming, driven by technology sector, skilled talent pool, and growing Global Capability Centers.

According to a report by CBRE South Asia Pvt Ltd and HYSEA, the city's office stock has more than tripled since 2014, ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

Diversifying investments with sector ETFs can reduce risks and enhance returns. Sector ETFs simplify targeted investments in different market areas, like tech or healthcare. Consider fund families ...

including 1,026 investors and 86 media representatives this year in a testament to the resilience and ingenuity of the biotech sector," said Sara Jane Demy, Founder and CEO of Demy-Colton.